{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:23:43Z","timestamp":1777958623072,"version":"3.51.4"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2015A030313808"],"award-info":[{"award-number":["2015A030313808"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.00832","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T04:12:56Z","timestamp":1564027976000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Comedication and Genetic Factors on the Population Pharmacokinetics of Lamotrigine: A Prospective Analysis in Chinese Patients With Epilepsy"],"prefix":"10.3389","volume":"10","author":[{"given":"Zhan-zhang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-can","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-jiao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-hua","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-shan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-guan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De-wei","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"arif2011","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/j.1528-1167.2011.03217.x","article-title":"The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy","volume":"52","author":"Arif","year":"2011","journal-title":"Epilepsia"},{"key":"arim2015","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/tpj.2015.78","article-title":"Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions","volume":"15","author":"Arimany-Nardi","year":"2015","journal-title":"Pharmacogenomics J."},{"key":"brza2014","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00228-013-1606-5","article-title":"Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients\u2013nonlinear mixed effects modelling approach","volume":"70","author":"Brzakovic","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"carg2018","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.phrs.2018.02.005","article-title":"Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: a systematic review and meta-analysis","volume":"131","author":"Cargnin","year":"2018","journal-title":"Pharmacol. Res."},{"key":"chan2001","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/00007691-200112000-00006","article-title":"Population pharmacokinetics of lamotrigine","volume":"23","author":"Chan","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"dick2012","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bcp.2011.12.032","article-title":"Lamotrigine is a substrate for OCT1 in brain endothelial cells","volume":"83","author":"Dickens","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"domj2018","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1111\/bcp.13646","article-title":"Interaction between ABCG2 421C > A polymorphism and valproate in their effects on steady-state disposition of lamotrigine in adults with epilepsy","volume":"84","author":"Domjanovic","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"gran2010","volume-title":"The genetic feterminants of lamotrigine dosing in epilepsy","author":"Grant","year":"2010"},{"key":"he2012","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/aps.2012.118","article-title":"Population pharmacokinetics of lamotrigine in Chinese children with epilepsy","volume":"33","author":"He","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"heye2018","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1124\/dmd.118.083030","article-title":"Polymorphisms of the multidrug pump ABCG2: a systematic review of their effect on protein expression, function, and drug pharmacokinetics","volume":"46","author":"Heyes","year":"2018","journal-title":"Drug. Metab. Dispos."},{"key":"hiem2018","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"hirs2004","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1212\/01.WNL.0000138424.33979.0C","article-title":"Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy","volume":"63","author":"Hirsch","year":"2004","journal-title":"Neurology"},{"key":"kaga2014","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/FTD.0000000000000088","article-title":"Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder","volume":"36","author":"Kagawa","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"kim2001","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1067\/mcp.2001.117412","article-title":"Identification of functionally variant MDR1 alleles among European Americans and African Americans","volume":"70","author":"Kim","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"kore2014","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/ejh.12235","article-title":"OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patients","volume":"92","author":"Koren-Michowitz","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"kroe2003","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00008571-200308000-00006","article-title":"Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene","volume":"13","author":"Kroetz","year":"2003","journal-title":"Pharmacogenetics"},{"key":"li2018","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2217\/pgs-2018-0114","article-title":"Impact of UGT2B7 and ABCC2 genetic polymorphisms on mycophenolic acid metabolism in Chinese renal transplant recipients","volume":"19","author":"Li","year":"2018","journal-title":"Pharmacogenomics"},{"key":"liao2005","first-page":"438","article-title":"The relationships between effectiveness and dosages, serum concentration, co-medications in epilepstic patients using lamotrigine","volume":"31","author":"Liao","year":"2005","journal-title":"Chin. J. Nerv. Ment. Dis."},{"key":"liu2015","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00228-015-1925-9","article-title":"Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C\u2005>\u2005T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children","volume":"71","author":"Liu","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"lovr2012","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/FTD.0b013e31826517c6","article-title":"Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy","volume":"34","author":"Lovric","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"mato2018","doi-asserted-by":"publisher","first-page":"e11349","DOI":"10.1186\/s13643-018-0773-y","article-title":"Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes: a systematic review","volume":"97","author":"Mato","year":"2018","journal-title":"Medicine"},{"key":"milo2016","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/bcp.12984","article-title":"Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: influence of polymorphism of UDP-glucuronosyltransferases and drug transporters","volume":"82","author":"Milosheska","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ni2011","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12032-010-9456-9","article-title":"Multidrug resistance gene (MDR1) polymorphisms correlate with imatinib response in chronic myeloid leukemia","volume":"28","author":"Ni","year":"2011","journal-title":"Med. Oncol."},{"key":"riva2008","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FTD.0b013e31817fd4d4","article-title":"Population pharmacokinetics of lamotrigine with data from therapeutic drug monitoring in German and Spanish patients with epilepsy","volume":"30","author":"Rivas","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"rome2015","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuropharm.2015.01.015","article-title":"The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)","volume":"93","author":"Romermann","year":"2015","journal-title":"Neuropharmacology"},{"key":"root1979","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF00644969","article-title":"Quantitative determination by HPLC of urinary 6beta-hydroxycortisol, an indicator of enzyme induction by rifampicin and antiepileptic drugs","volume":"16","author":"Roots","year":"1979","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"rudi2008","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1200\/JCO.2007.13.1128","article-title":"Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity","volume":"26","author":"Rudin","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"saek2005","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2133\/dmpk.20.144","article-title":"Genetic variations and haplotypes of UGT1A4 in a Japanese population","volume":"20","author":"Saeki","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"serr2013","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchromb.2013.02.026","article-title":"First HPLC-UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma","volume":"925","author":"Serralheiro","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"shen2016a","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.eplepsyres.2016.09.004","article-title":"Specific OCT1 and ABCG2 polymorphisms are associated with Lamotrigine concentrations in Chinese patients with epilepsy","volume":"127","author":"Shen","year":"2016","journal-title":"Epilepsy Res."},{"key":"shen2016b","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/aps.2016.24","article-title":"Population pharmacokinetic modeling and simulation of huperzine A in elderly Chinese subjects","volume":"37","author":"Sheng","year":"2016","journal-title":"Acta Pharmacol. Sin"},{"key":"shik2007","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10038-006-0087-0","article-title":"Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin","volume":"52","author":"Shikata","year":"2007","journal-title":"J. Hum. Genet."},{"key":"sidd2003","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":"Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"sing2012","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0051771","article-title":"SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia","volume":"7","author":"Singh","year":"2012","journal-title":"PLoS One"},{"key":"sing2013","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00228-012-1449-5","article-title":"Influence of the UGT2B7 -161C > T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients","volume":"69","author":"Singkham","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"smit2018","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/FTD.0000000000000540","article-title":"Clinically relevant effect of UGT1A4*3 on lamotrigine serum concentration is restricted to postmenopausal women\u2014a study matching therapeutic drug monitoring and genotype data from 534 patients","volume":"40","author":"Smith","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"suzu2019","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/FTD.0000000000000577","article-title":"Relationship between UGT1A4 and UGT2B7 polymorphisms and the steady-state plasma concentrations of lamotrigine in patients with treatment-resistant depressive disorder receiving lamotrigine as augmentation therapy","volume":"41","author":"Suzuki","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"tamu2007","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2133\/dmpk.22.428","article-title":"In vitro evaluation of photosensitivity risk related to genetic polymorphisms of human ABC transporter ABCG2 and inhibition by drugs","volume":"22","author":"Tamura","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"tan2005","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/archneur.62.3.460","article-title":"Effect of MDR1 haplotype on risk of Parkinson disease","volume":"62","author":"Tan","year":"2005","journal-title":"JAMA Neurol."},{"key":"tang2002","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00008571-200208000-00004","article-title":"Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations","volume":"12","author":"Tang","year":"2002","journal-title":"Pharmacogenetics"},{"key":"tara2012","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/FPC.0b013e3283561666","article-title":"Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients","volume":"22","author":"Tarasova","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"vand2018","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s40262-017-0614-5","article-title":"Effect of age-related factors on the pharmacokinetics of lamotrigine and potential implications for maintenance dose optimisation in future clinical trials","volume":"57","author":"van Dijkman","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"viva2019","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/uog.19018","article-title":"Optimal non-invasive diagnosis of fetal achondroplasia combining ultrasonography with circulating cell-free fetal DNA analysis","volume":"53","author":"Vivanti","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"wan2015","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1124\/jpet.115.225045","article-title":"Marked alteration of rosuvastatin pharmacokinetics in healthy Chinese with ABCG2 34G > A and 421C > A homozygote or compound heterozygote","volume":"354","author":"Wan","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"wang2015","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.dmpk.2014.12.007","article-title":"Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy","volume":"30","author":"Wang","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"zhan2008","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1080\/00498250802488585","article-title":"Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients","volume":"38","author":"Zhang","year":"2008","journal-title":"Xenobiotica"},{"key":"zhan2017","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00228-016-2190-2","article-title":"Population pharmacokinetic models of lamotrigine in different age groups of Chinese children with epilepsy","volume":"73","author":"Zhang","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"zhen2002","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0198-8859(02)00426-3","article-title":"The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients","volume":"63","author":"Zheng","year":"2002","journal-title":"Hum. Immunol."},{"key":"zhou2015","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.dmpk.2015.05.002","article-title":"Polymorphisms of ABCG2, ABCB1 and HNF4\u03b1 are associated with Lamotrigine trough concentrations in epilepsy patients","volume":"30","author":"Zhou","year":"2015","journal-title":"Drug Metab. Pharmacokinet."},{"key":"zhu2017","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/aps.2016.163","article-title":"Development of a novel individualized warfarin dose algorithm based on a population pharmacokinetic model with improved prediction accuracy for Chinese patients after heart valve replacement","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00832\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T22:39:18Z","timestamp":1569105558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.00832\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":50,"alternative-id":["10.3389\/fphar.2019.00832"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.00832","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"article-number":"832"}}